welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)

key information

study id #: NCT04184882

condition: Duchenne Muscular Dystrophy (DMD)

status: recruiting


The primary purpose of this study is to evaluate the safety and tolerability of ASP0367.

This study will also evaluate the pharmacokinetics, pharmacodynamics and efficacy on muscle function of ASP0367.

intervention: ASP0367, Placebo

mechanism of action: Peroxisome proliferator-activated receptor delta modulators

results: https://clinicaltrials.gov/ct2/show/results/NCT04184882

last updated: December 09, 2020